Literature DB >> 9192045

Virus-like particle vaccines for mucosal immunization.

M K Estes1, J M Ball, S E Crawford, C O'Neal, A A Opekun, D Y Graham, M E Conner.   

Abstract

Viruses which infect the gastrointestinal tract are well suited for examining the immune response(s) to oral delivery of antigen and exploring the advantages and pitfalls of oral vaccines. We have used recombinant DNA techniques to produce nonreplicating self-assembled virus-like particles (VLPs) from two gastrointestinal viruses, rotavirus and Norwalk virus. Both of these viruses normally cause acute gastroenteritis in man or animals. The VLPs are morphologically and antigenically similar to the native virus and quite stable, features which are advantageous for their use as subunit vaccines. In addition, these VLPs could be useful as carriers of foreign epitopes from heterologous pathogens or of drugs which need to be delivered to the gastrointestinal track. This paper briefly reviews the properties of these VLPs made in insect cells and data showing their potential as subunit vaccines for parenteral or oral delivery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192045     DOI: 10.1007/978-1-4899-1828-4_61

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

Review 1.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

2.  Molecular epidemiology of outbreaks of gastroenteritis associated with small round-structured viruses in East Anglia, United Kingdom, during the 1996-1997 season.

Authors:  A J Maguire; J Green; D W Brown; U Desselberger; J J Gray
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

3.  Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence.

Authors:  M Zhang; C Q Zeng; Y Dong; J M Ball; L J Saif; A P Morris; M K Estes
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998.

Authors:  M Iturriza-Gómara; J Green; D W Brown; M Ramsay; U Desselberger; J J Gray
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Rotavirus-like particles: a novel nanocarrier for the gut.

Authors:  Naima G Cortes-Perez; Catherine Sapin; Loïc Jaffrelo; Sabine Daou; Jean Pierre Grill; Philippe Langella; Philippe Seksik; Laurent Beaugerie; Serge Chwetzoff; Germain Trugnan
Journal:  J Biomed Biotechnol       Date:  2010-04-13

6.  Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding.

Authors:  Haruko Shirato; Satoko Ogawa; Hiromi Ito; Takashi Sato; Akihiko Kameyama; Hisashi Narimatsu; Zheng Xiaofan; Tatsuo Miyamura; Takaji Wakita; Koji Ishii; Naokazu Takeda
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

7.  Structural basis for the recognition of Lewis antigens by genogroup I norovirus.

Authors:  Tomomi Kubota; Akiko Kumagai; Hiromi Ito; Sanae Furukawa; Yuichi Someya; Naokazu Takeda; Koji Ishii; Takaji Wakita; Hisashi Narimatsu; Haruko Shirato
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

8.  Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.

Authors:  L Yuan; A Geyer; D C Hodgins; Z Fan; Y Qian; K O Chang; S E Crawford; V Parreño; L A Ward; M K Estes; M E Conner; L J Saif
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Norovirus recognition sites on histo-blood group antigens.

Authors:  Haruko Shirato
Journal:  Front Microbiol       Date:  2012-05-17       Impact factor: 5.640

10.  Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.

Authors:  Kelly L Warfield; John M Dye; Jay B Wells; Robert C Unfer; Frederick W Holtsberg; Sergey Shulenin; Hong Vu; Dana L Swenson; Sina Bavari; M Javad Aman
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.